Dicerna Pharmaceuticals Inc·4

Jun 15, 4:16 PM ET

Dicerna Pharmaceuticals Inc 4

4 · Dicerna Pharmaceuticals Inc · Filed Jun 15, 2016

Insider Transaction Report

Form 4
Period: 2016-06-14
MADDEN DAVID
Director
Transactions
  • Award

    Director Stock Option (right to buy)

    2016-06-14+20,00020,000 total
    Exercise: $3.26Exp: 2026-06-14Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The option vests in full on June 14, 2017 subject to the Reporting Person's continued service to the Issuer through such date.

Documents

2 files